Oncternal Therapeutics to Provide Business Update and Report First Quarter 2023 Financial Results

April 27, 2023

https://www.globenewswire.com/news-release/2023/04/27/2656981/0/en/Oncternal-Therapeutics-to-Provide-Business-Update-and-Report-First-Quarter-2023-Financial-Results.html

SAN DIEGO, April 27, 2023 (GLOBE NEWSWIRE) — Oncternal Therapeutics, Inc. (Nasdaq:ONCT), a clinical-stage biopharmaceutical company focused on the development of novel oncology therapies, today announced that it will report first quarter 2023 financial results after the U.S. financial markets close on Thursday, May 4, 2023. Oncternal’s management will host a webcast at 2:00 p.m. PT (5:00 p.m. ET) to provide a comprehensive business update and discuss the Company’s financial results.

Read more at globenewswire.com

Related news for (ONCT)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.